Du är här


Santhera Pharmaceuticals Holding AG: Santhera to Present Financial Figures for 2013 and Outlook at Swiss Biotech Day 2014

Santhera Pharmaceuticals Holding AG / Santhera to Present Financial Figures
for 2013 and Outlook at Swiss Biotech Day2014 . Processed and transmitted by
NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the
content of this announcement.
Liestal, Switzerland, April 4, 2014
- Santhera Pharmaceuticals (SIX: SANN) announced today that Thomas Meier,
Chief Executive Officer of Santhera, will present at the upcoming
Swiss Biotech Day on Tuesday, April 8, 2014. Mr Meier will
an update on forthcoming regulatory and development milestones and present
financial results
for 2013 and for the first quarter of 2014. The presentation will be available
for download on the Company's website

. In compliance with SIX regulations,
the news release and Annual Report will be published on April 8, 2014, at
07:00 CET.

The Swiss Biotech Day is the leading biotechnology conference in Switzerland.
Every year, this event brings together more than 200 senior executives from
the life science industry across Europe. Program highlights will include the
presentation of the Swiss biotech report and key note lectures by renowned
industry leaders and scientists. The event is being held at the Kongresshaus,
Gotthardtrasse 5, in Zurich, Switzerland.

* * *

About Santhera
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical
company focused on the development and commercialization of innovative
pharmaceutical products for the treatment of orphan mitochondrial and
neuromuscular diseases, such as Leber's Hereditary Optic Neuropathy, Duchenne
Muscular Dystrophy and primary progressive Multiple Sclerosis, all of them
areas of high unmet medical need with no current therapies. For further
information, please visit the Company's websitewww.santhera.com.

For further information, contact
Thomas Meier, Chief Executive Officer
Phone: +41 61 906 89 64

Disclaimer / Forward-looking statements
This communication does not constitute an offer or invitation to subscribe for
or purchase any securities of Santhera Pharmaceuticals Holding AG. This
publication may contain certain forward-looking statements concerning the
Company and its business. Such statements involve certain risks,
uncertainties and other factors which could cause the actual results,
financial condition, performance or achievements of the Company to be
materially different from those expressed or implied by such statements.
Readers should therefore not place undue reliance on these statements,
particularly not in connection with any contract or investment decision. The
Company disclaims any obligation to update these forward-looking statements.

Swiss Biotech Day


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Santhera Pharmaceuticals Holding AG via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.